Development of purified glycogen derivatives as siRNA nanovectors
Giuseppe Francesco Racaniello(University of Bari Aldo Moro), Nunzio Denora(University of Bari Aldo Moro), Juliette Vergnaud(Centre National de la Recherche Scientifique), Valentino Laquintana(University of Bari Aldo Moro), Francesco Leonetti(University of Bari Aldo Moro), Paola Pontrelli(University of Bari Aldo Moro), Annalisa Cutrignelli(University of Bari Aldo Moro), Antonio Lopalco(University of Bari Aldo Moro), Elias Fattal(Centre National de la Recherche Scientifique), Mauro Fiume(University of Bari Aldo Moro), Loreto Gesualdo(Unknown), Massimo Franco(University of Bari Aldo Moro), Angela Lopedota(University of Bari Aldo Moro)
Cited by 8
Related Papers
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
|The Lancet|2023|264
The copy number variation landscape of congenital anomalies of the kidney and urinary tract
|Nature Genetics|2018|240
Thiolated polymeric hydrogels for biomedical application: Cross-linking mechanisms
|Journal of Controlled Release|2020|208
Genetic Drivers of Kidney Defects in the DiGeorge Syndrome
|New England Journal of Medicine|2017|154
Exome-wide Association Study Identifies GREB1L Mutations in Congenital Kidney Malformations
|The American Journal of Human Genetics|2017|106